Page last updated: 2024-10-31

nafamostat and Heart Valve Diseases

nafamostat has been researched along with Heart Valve Diseases in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research Excerpts

ExcerptRelevanceReference
"A 58-year old woman with idiopathic thrombocytopenic purpura underwent mitral and aortic valve replacements and tricuspid annuloplasty."1.31Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura. ( Matsuzaki, Y; Nagahama, H; Nakamura, E; Nakamura, K; Onitsuka, T; Yano, M, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoshino, R1
Okubo, T1
Kaneko, K1
Goko, C1
Nakamura, K1
Onitsuka, T1
Yano, M1
Nagahama, H1
Nakamura, E1
Matsuzaki, Y1

Other Studies

2 other studies available for nafamostat and Heart Valve Diseases

ArticleYear
[Cardiac surgery in hemodialysis patients].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1993, Volume: 41, Issue:7

    Topics: Adult; Antithrombins; Benzamidines; Coronary Artery Bypass; Extracorporeal Circulation; Female; Guan

1993
Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura.
    The Annals of thoracic surgery, 2000, Volume: 70, Issue:6

    Topics: Anticoagulants; Aortic Valve; Benzamidines; Cardiopulmonary Bypass; Female; Guanidines; Heart Valve

2000